Mindfulness for Anxiety Disorders: What Research Shows
Updated: Oct 8
Author: Ukrainian Psychological Hub · Published: October 1, 2026 · Editorial Policy
Mindfulness can reduce anxiety symptoms and can be clinically useful for some people with diagnosed anxiety disorders. The strongest evidence concerns structured mindfulness-based programs rather than a few minutes of unguided meditation, and the evidence is not equally strong for every anxiety disorder. A large randomized trial found an eight-week Mindfulness-Based Stress Reduction program, or MBSR, noninferior to escitalopram for overall clinical severity in adults with several anxiety disorders, while systematic reviews show that results depend heavily on the comparison condition, diagnosis, program, and follow-up period. Hoge et al. (2023) and Haller et al. (2021) provide two of the most informative sources for that conclusion.
The clinical meaning of this evidence is specific. Mindfulness is a treatment approach or treatment component, not a diagnosis and not a single standardized therapy. It does not make every form of anxiety equivalent, and it does not replace disorder-specific interventions simply because anxious symptoms are present. Anxiety disorders include distinct conditions with different maintaining mechanisms and treatment evidence, so generalized anxiety disorder, panic disorder, agoraphobia, social anxiety disorder, specific phobia, separation anxiety disorder, and selective mutism should keep their own diagnostic and treatment boundaries.
This article focuses on clinical anxiety and fear-related disorders. Normal worry, transient fear, stress responses, and occasional nervousness are common human experiences. A screening score or a response to meditation does not establish a psychiatric diagnosis. Formal assessment considers symptom pattern, duration, impairment, context, medical and substance-related explanations, and relevant differential diagnoses; see How Is Anxiety Diagnosed? Assessment, History, and Differential Diagnosis for the broader assessment framework.
The short answer: does mindfulness work for anxiety disorders?
Yes, structured mindfulness-based interventions can reduce anxiety symptoms in some adults with anxiety disorders. The best-supported programs are usually multiweek, manualized interventions such as MBSR and Mindfulness-Based Cognitive Therapy, or MBCT. Across the broader mindfulness literature, benefits are generally clearer against waitlist, treatment-as-usual, or other passive comparisons than against credible active treatments. A systematic review of 44 meta-analyses covering 336 randomized trials and more than 30,000 participants found that mindfulness-based interventions usually outperformed passive controls, while effects were smaller and less consistently significant against active controls. Goldberg et al. (2022) summarized this pattern across clinical and nonclinical populations.
For anxiety disorders specifically, a 2021 meta-analysis of 23 studies involving 1,815 adults found short-term benefit from standardized acceptance- and mindfulness-based interventions compared with treatment as usual. When compared with cognitive behavioral therapy, ACT and MBCT showed comparable pooled effects, whereas MBSR showed lower effects in that analysis; longer-term comparisons did not demonstrate a clear advantage for mindfulness-based approaches. Adverse-event reporting was also insufficient. Haller et al. (2021) therefore supports clinical usefulness while also showing why the phrase “mindfulness works” is too broad to describe the evidence accurately.
Current guidance reflects the same distinction. The World Health Organization anxiety fact sheet notes that mindfulness skills can help reduce symptoms, while also emphasizing established psychological treatments such as cognitive behavioral therapy and exposure. WHO’s mhGAP evidence center gives relaxation and/or mindfulness training a conditional recommendation with low certainty of evidence for adults with generalized anxiety disorder and/or panic disorder. This recommendation should not be silently extended to every anxiety disorder.
What researchers mean by mindfulness
Mindfulness research uses the same word for several related but different things. At the simplest level, mindfulness refers to deliberately attending to present-moment experience with an attitude that reduces automatic judgment and reactivity. In treatment research, however, investigators usually study a program, not a single mental act. A full program can include repeated meditation practice, psychoeducation, discussion, homework, body awareness, mindful movement, and strategies for responding differently to difficult thoughts, emotions, and sensations.
Mindfulness-Based Stress Reduction
MBSR is a structured program originally developed outside the anxiety-disorder field. In modern trials it is commonly delivered over eight weeks with weekly classes, home practice, and instruction in practices such as breath awareness, body scanning, sitting meditation, and mindful movement. Evidence from a manualized MBSR course cannot automatically be transferred to a meditation app, a brief breathing exercise, an informal social-media practice, or an intensive silent retreat.
Mindfulness-Based Cognitive Therapy
MBCT combines mindfulness practices with elements derived from cognitive therapy. Its best-established clinical role historically concerns recurrent depression, but MBCT has also been studied in anxiety disorders. Because MBCT is a multicomponent intervention, improvement after MBCT does not prove that meditation alone caused the change.
Mindfulness meditation, trait mindfulness, and apps
A person can practice mindfulness meditation without receiving MBSR or MBCT. Researchers also measure dispositional or trait mindfulness using questionnaires, which is a different research target again. Higher self-reported mindfulness can correlate with lower anxiety, but correlation does not show that increasing a questionnaire score will treat an anxiety disorder. Digital programs add another layer: online delivery can range from clinician-led videoconference classes to automated modules and consumer apps, and those formats should not be treated as interchangeable.
What the strongest comparative trial found
The most prominent direct comparison is the TAME randomized clinical trial. Investigators enrolled 276 adults with a diagnosed primary anxiety disorder at three U.S. academic medical centers. Eligible diagnoses included generalized anxiety disorder, social anxiety disorder, panic disorder, and agoraphobia. Participants were randomized to eight weeks of standardized MBSR or escitalopram, a selective serotonin reuptake inhibitor, with blinded clinician ratings. In the primary completer sample of 208 participants, improvement in Clinical Global Impression of Severity scores met the trial’s prespecified criterion for noninferiority of MBSR to escitalopram at eight weeks. Hoge et al. (2023) reported the primary findings.
This result is important because it compared MBSR with an active first-line medication rather than with a waitlist. It still has boundaries. It was one trial of one standardized mindfulness program, one medication, a selected adult sample, and a mixed group of anxiety diagnoses. “MBSR was noninferior to escitalopram in this trial” does not mean that all meditation is equivalent to antidepressant treatment, that every person will respond equally, or that MBSR has been shown to be equivalent to every evidence-based treatment for every anxiety disorder.
The safety profiles also differed in the trial. Among participants who started treatment, study-related adverse events were reported much more often in the escitalopram group than in the MBSR group, and ten participants discontinued escitalopram because of adverse events while none discontinued MBSR for that reason. Those findings describe this particular trial; they do not establish that mindfulness is risk-free. Hoge et al. (2023) and the later patient-reported secondary analysis by Hu et al. (2024) should be read together when evaluating the comparison.
A later phase of the same research program examined synchronous videoconference delivery. In 202 adults randomized to videoconference MBSR or videoconference escitalopram, average improvement did not differ significantly, but the prespecified noninferiority criterion for MBSR versus escitalopram was not met. Videoconference MBSR was noninferior to in-person MBSR on the study’s primary clinical-severity outcome, although the delivery-format comparison itself was not randomized because it arose across pre-pandemic and pandemic cohorts. Hoge et al. (2025) makes the digital-delivery evidence more useful while also showing why “no significant difference” and “proven noninferiority” are not the same statistical claim.
Evidence differs by anxiety disorder
Anxiety disorders share features such as threat anticipation, distress, and avoidance, but treatment evidence remains diagnosis-specific. A transdiagnostic mindfulness result can inform clinical reasoning without erasing the differences between persistent generalized worry, panic-related fear of bodily sensations, fear of social evaluation, and a circumscribed phobic fear.
Generalized anxiety disorder
Among individual anxiety disorders, generalized anxiety disorder has one of the clearer mindfulness evidence bases. A 2023 systematic review and meta-analysis identified eight articles representing four independent studies and 334 adults with diagnosed GAD who received eight-week manualized mindfulness training. Mindfulness showed a large pooled effect on anxiety compared with inactive or unspecified controls, but it did not show a significant advantage over active controls. The review judged the evidence limited by the small number of studies, risk of bias, and low certainty. Williams et al. (2023) is therefore supportive evidence for GAD, with substantial uncertainty about comparative efficacy.
Broader psychotherapy evidence places this in context. A network meta-analysis of 65 randomized studies and 5,048 adults with GAD found CBT, third-wave CBTs, and relaxation therapy superior to treatment as usual in the acute phase; after longer follow-up, only CBT retained a significant advantage over treatment as usual. The authors concluded that CBT should be considered a first-line psychological treatment for GAD. Papola et al. (2024) supports offering mindfulness-based or third-wave approaches as options without displacing the stronger long-term evidence for CBT.
The practical treatment landscape is covered in Generalized Anxiety Disorder Treatment: CBT, Medication, and Self-Help. Mindfulness may be used as a structured treatment approach, an adjunct, or a stress-management skill depending on the person, program, and clinical context.
Panic disorder and agoraphobia
Panic disorder requires special care because panic attacks often involve intense bodily sensations and fear of what those sensations mean. The TAME trial included panic disorder and agoraphobia, and WHO’s mhGAP recommendation specifically includes panic disorder in its conditional, low-certainty recommendation for relaxation and/or mindfulness training. WHO’s stress-management recommendation provides the most direct guideline-level support for this use.
Mindfulness can help a person notice bodily sensations, catastrophic thoughts, and urges to escape without automatically reacting to them. That rationale overlaps with treatment targets in panic disorder, but it should not be confused with interoceptive exposure. Panic-focused CBT deliberately tests feared predictions and systematically changes avoidance of bodily sensations and situations. NICE guidance for panic disorder recommends CBT and, in appropriate cases, antidepressant treatment; mindfulness is not presented there as a replacement for panic-focused CBT.
For people with panic disorder, the relevant question is therefore not whether mindfulness can make anxiety disappear during a panic episode. A more useful question is whether a structured practice helps change the person’s relationship to sensations and fear while the core maintaining cycle—catastrophic interpretation, anticipatory anxiety, avoidance, and safety behavior—is also addressed. See Panic Disorder Treatment: CBT, Exposure, Medication, and Self-Help for the disorder-specific treatment evidence.
Social anxiety disorder
Social anxiety disorder has direct randomized and meta-analytic mindfulness evidence. In a randomized trial of 108 unmedicated adults with generalized social anxiety disorder, both cognitive behavioral group therapy and MBSR improved most outcomes compared with waitlist, and the two active treatments produced similar improvement on several measures. CBT produced larger reductions in subtle avoidance behavior. Goldin et al. (2016) provides an unusually informative head-to-head comparison because it measured both symptoms and proposed mechanisms.
A later systematic review and meta-analysis reached a more cautious overall conclusion. Across eleven randomized trials, mindfulness-based interventions were superior to no treatment, similar to some active treatments, and less effective than evidence-based CBT on social-anxiety outcomes. Liu et al. (2021) found that benefits could persist at follow-up, but the comparative result matters: mindfulness has evidence for social anxiety, yet disorder-specific CBT remains a major reference treatment.
This is why a general mindfulness page should not own the broader social-anxiety treatment intent. That evidence belongs with Social Anxiety Disorder Treatment: CBT, Exposure, Medication, and Self-Help. Mindfulness can be one route to reducing self-focused reactivity and increasing willingness to remain present in feared social situations, while exposure and behavioral experiments directly target avoidance, safety behavior, and feared social predictions.
Specific phobia
The evidence base is different for specific phobia. The central evidence-based psychological intervention is exposure to the feared object or situation in a planned therapeutic framework. Mindfulness may support attention, willingness, and tolerance of fear during treatment, but current evidence does not justify treating mindfulness as an evidence-equivalent substitute for exposure therapy for specific phobia. The WHO mhGAP mindfulness recommendation for GAD and panic disorder explicitly does not establish a recommendation for specific phobia.
For the treatment mechanism and clinical process, see Exposure Therapy for Specific Phobia: How It Works and What to Expect. A person can use mindful awareness during exposure, but the therapeutic target remains learning through contact with the feared cue rather than trying to use mindfulness to suppress fear.
Separation anxiety disorder and selective mutism
Direct disorder-specific evidence for mindfulness as a primary treatment is much thinner for separation anxiety disorder and selective mutism, especially in children. These conditions require developmental assessment and treatment planning that may involve parents, school environments, behavioral methods, graded exposure, and disorder-specific CBT strategies. Adult MBSR trials should not be generalized to pediatric separation anxiety or selective mutism simply because anxiety is present.
The appropriate evidence label here is limited. Mindfulness skills may be incorporated into broader care when clinically appropriate, but the research base is not comparable to the evidence supporting structured behavioral and cognitive-behavioral approaches for these conditions.
How mindfulness compares with CBT and exposure therapy
Mindfulness and CBT overlap in some processes but are not interchangeable. CBT for anxiety disorders may include psychoeducation, cognitive restructuring, behavioral experiments, exposure, response prevention of safety behaviors, worry-focused methods, interoceptive exposure, attention training, and relapse planning depending on the diagnosis. Mindfulness-based programs emphasize present-moment awareness, acceptance, and a less reactive relationship to thoughts and sensations.
Related treatment approaches have their own evidence bases. Exposure Therapy for Anxiety Disorders: In Vivo, Interoceptive, and Imaginal Exposure explains the learning-focused treatment of feared cues and avoidance, while Relaxation Training for Anxiety: Evidence, Uses, and Limitations covers arousal-management skills such as progressive muscle relaxation and applied relaxation. These approaches can overlap in a treatment plan without becoming interchangeable with mindfulness.
The strongest synthesis of mindfulness-based interventions across DSM-5 anxiety disorders found that some mindfulness- and acceptance-based approaches produced short-term benefits and, in pooled comparisons, ACT and MBCT could look similar to CBT, whereas MBSR showed lower effects than CBT. Longer-term differences were less clear, and heterogeneity was substantial. Haller et al. (2021) therefore supports a treatment-choice framework rather than a claim that one family of interventions has replaced another.
For fear-dominant disorders, the distinction is especially important. Exposure changes what happens when a person encounters feared sensations, situations, objects, or social outcomes. Mindfulness may help a person stay in contact with that experience without escalating struggle, but a practice used primarily to calm down, distract, or escape can become a safety behavior if it is required before the person will face the feared situation. The function of the practice matters.
How mindfulness compares with medication
The MBSR-versus-escitalopram trial provides unusually strong comparative evidence, but it should be interpreted at the treatment-program level. Escitalopram is a medication with dosing, contraindications, adverse-effect monitoring, and withdrawal considerations. MBSR is a time-intensive behavioral program that requires instruction and substantial practice. Similar average symptom change in a trial does not make their burdens, risks, mechanisms, or suitability identical.
Medication decisions also differ by diagnosis, medical history, other medications, pregnancy considerations, prior response, adverse effects, and patient preference. A general educational article cannot determine whether a reader should start, stop, switch, or taper a medication. The WHO anxiety fact sheet and NICE guidance both place treatment choice in a broader clinical framework rather than treating one technique as universally appropriate.
How mindfulness may reduce anxiety
Several mechanisms are plausible. Mindfulness practice may improve the ability to notice a thought as a mental event rather than as a fact, identify bodily arousal earlier, remain with discomfort without immediately escaping, reduce automatic elaboration of worry, and shift attention with greater flexibility. These processes are often described as mindful attention, decentering, acceptance, and reduced reactivity.
Mechanism evidence is meaningful but still incomplete. A 2022 systematic review and meta-analysis of mediation studies found a small-to-medium pooled indirect effect for mindful attention, decentering, and acceptance across anxiety and depression trials. However, studies using stronger time-lagged causal mediation methods did not show the same clear mediation signal, and specificity could not be established. Johannsen et al. (2022) supports these processes as candidates rather than as fully proven causal pathways.
This distinction matters for clinical explanations. It is reasonable to say that mindfulness trains ways of attending and responding that may interrupt worry and reactivity. It is much stronger to claim that a particular mechanism has been proven to cause recovery from an anxiety disorder. Current evidence supports the first statement more firmly than the second.
Online mindfulness, videoconference programs, and apps
Digital delivery can expand access, but “online mindfulness” includes very different interventions. A live eight-week MBSR class delivered by a trained teacher through videoconference has more in common with in-person MBSR than with a consumer app offering short prerecorded exercises. The 2025 TAME extension found videoconference MBSR comparable to in-person MBSR on the primary severity outcome, although the remote-versus-in-person comparison was not randomized. Hoge et al. (2025) supports synchronous remote delivery while preserving important design limitations.
Meta-analytic evidence for online mindfulness interventions is broader and less diagnosis-specific. A 2023 review of 26 studies with 3,246 adults found a small overall benefit for anxiety symptoms compared with controls, with very high heterogeneity. Reangsing et al. (2023) did not establish that online mindfulness is equivalent to clinician-led treatment for a diagnosed anxiety disorder.
A newer 2026 meta-analysis of structured online mindfulness curricula found reductions in anxiety symptoms across 25 comparisons involving 3,890 participants, but again the populations and indications were broader than one specific anxiety diagnosis. Tong et al. (2026) strengthens the evidence that structured digital mindfulness can affect anxiety symptoms while leaving the disorder-specific treatment question open.
Consumer apps should therefore be judged by what they actually deliver. Evidence for MBSR does not automatically validate an app because it contains the word mindfulness. Relevant questions include whether the program follows a studied curriculum, whether there is qualified guidance, how much practice is required, what population was studied, whether symptom worsening is monitored, and whether the user has a diagnosis or risk profile that needs individualized care.
How long does mindfulness take to work?
The best-known anxiety-disorder trials usually study structured programs lasting about eight weeks, often with weekly classes and substantial home practice. That research does not create a universal biological deadline. Some people notice changes earlier, some later, and some do not improve. Symptom variation during treatment is also normal and should not be confused with a final outcome.
There is no scientifically established rule that ten minutes, twenty minutes, or another single daily dose is sufficient to treat an anxiety disorder. Studies differ in class length, home-practice expectations, teacher contact, adherence, population, and outcome measures. Practice dose can matter, but the field does not support converting one program’s schedule into a universal prescription.
For someone using mindfulness as part of clinical treatment, progress is better judged by changes in the actual problem: frequency and intensity of worry or panic, avoidance, ability to function, interference with work or relationships, distress, sleep, and disorder-specific outcomes. A person can become more skilled at mindfulness while still needing additional treatment.
Can mindfulness make anxiety worse?
Mindfulness and meditation are often described as low-risk, but low-risk is not the same as risk-free. Increased awareness of bodily sensations, thoughts, or traumatic material can initially feel uncomfortable, and some people report increases in anxiety, distress, dissociation-like experiences, or other difficult reactions. A systematic review of meditation-related adverse events found substantial inconsistency in how harms were defined and measured, which makes exact prevalence estimates difficult to generalize. Farias et al. (2020) is an important reminder that safety should be monitored rather than assumed.
The context of practice matters. A standard, adaptable MBSR or MBCT program is different from prolonged or intensive meditation. People with a history of severe destabilization, mania, psychosis, significant dissociation, or trauma-related re-experiencing may need more individualized planning around meditation intensity and format. If practice repeatedly produces sustained worsening, functional impairment, severe panic, disorientation, or other concerning changes, that is a reason to modify or stop the practice and seek professional assessment rather than forcing more exposure to the exercise.
Mindfulness should also not be used to explain away physical symptoms. Chest pain, fainting, new neurological symptoms, severe shortness of breath, or other potentially significant medical symptoms cannot be safely classified as anxiety by similarity alone. A mindfulness exercise is not a diagnostic test and should not delay appropriate medical evaluation.
Mindfulness during a panic attack
During acute panic, mindfulness can be used as a way of noticing sensations and thoughts without adding a second struggle against them. The therapeutic intention is usually observation and willingness, not proving that nothing is happening or forcing the body to calm down immediately. For some people, close attention to breathing or internal sensations can temporarily intensify fear, especially when fear of bodily sensations is central.
That is why panic treatment should be individualized. A clinician using panic-focused CBT may deliberately work with feared sensations through interoceptive exposure, while mindfulness may be used to support nonreactive observation. If a person turns a mindfulness ritual into something they believe must be performed to prevent catastrophe, the ritual can function as a safety behavior and preserve the fear cycle.
Who may consider a structured mindfulness program?
A structured mindfulness program may be reasonable for an adult who prefers a nonpharmacological approach, has access to a qualified program, understands the time commitment, and has symptoms or a diagnosed anxiety disorder for which the evidence is relevant. It may also be used alongside CBT, medication, or another treatment when the combined plan is coherent and monitored.
Preference matters because treatment adherence depends partly on whether a person can realistically engage with the method. MBSR asks for repeated practice and substantial time. Someone who strongly dislikes sustained meditation is not failing treatment by preferring a different evidence-based option. Likewise, a person who values mindfulness may be more willing to complete a structured program than a treatment they do not want.
The choice becomes more clinically important when anxiety causes marked impairment, has persisted despite self-help, co-occurs with depression or another disorder, or involves diagnostic uncertainty. In those situations, treatment selection should follow assessment rather than a generic internet rule.
What an evidence-aligned mindfulness program looks like
A credible program identifies what it is. It should be possible to tell whether the intervention is MBSR, MBCT, another manualized mindfulness-based intervention, a clinician-developed adjunct, or general meditation instruction. The program should also describe the expected schedule, teacher qualifications, home practice, target population, and how difficulties are handled.
In clinical care, outcome monitoring matters. Improvement should be evaluated with relevant symptoms and functioning, not only by whether a person completed meditation sessions or reports feeling mindful. If the target is social anxiety, social avoidance and impairment matter. If the target is panic disorder, panic frequency, anticipatory fear, avoidance, and fear of sensations matter. If the target is GAD, excessive uncontrollable worry and associated impairment matter.
A program should also leave room to change course. Mindfulness is one treatment pathway among several. Lack of improvement after an adequate trial can justify reassessment of diagnosis, adherence, comorbidity, treatment fit, and alternative evidence-based interventions.
What the research does not show
Current evidence does not show that every person with anxiety should meditate, that mindfulness cures anxiety disorders, that a brief app exercise is equivalent to MBSR, that symptom improvement proves a permanent change in personality or brain structure, or that mindfulness should replace exposure in fear-based disorders. It also does not justify using adult GAD or mixed-anxiety trials as direct evidence for selective mutism, pediatric separation anxiety, OCD, PTSD, illness anxiety, or other neighboring conditions.
It is also inaccurate to infer that mindfulness and medication are universally interchangeable from one noninferiority trial. The TAME study establishes an important result for standardized MBSR and escitalopram in a defined adult sample. Treatment equivalence across drugs, doses, disorders, age groups, delivery methods, and clinical settings would require separate evidence.
The most defensible synthesis is narrower and more useful: structured mindfulness-based programs have a real evidence base for anxiety symptoms and several adult anxiety disorders; the strength of evidence varies by diagnosis and comparator; CBT and exposure remain central evidence-based treatments; and treatment choice should reflect the disorder, person, program, risk profile, and available care.
Frequently asked questions
Is mindfulness a first-line treatment for anxiety disorders?
There is no single answer across all anxiety disorders. WHO considers relaxation and/or mindfulness training for adults with GAD and panic disorder, but the recommendation is conditional and based on low-certainty evidence. NICE guidance for GAD and panic disorder emphasizes CBT, applied relaxation for GAD, and medication or self-help options depending on severity and preference. For social anxiety and specific phobia, disorder-specific CBT and exposure evidence remains especially important.
Is MBSR the same as meditation?
No. Meditation practices are components of MBSR, but MBSR is a structured multiweek program with instruction, group sessions, home practice, and a defined curriculum. Evidence for MBSR should be attributed to the whole program unless a study isolates a specific component.
Is MBCT better than MBSR for anxiety?
The evidence does not support a universal ranking. MBCT and MBSR differ in structure and theoretical background, studies enroll different populations, and direct head-to-head comparisons are limited. Some meta-analytic findings favor certain mindfulness- or acceptance-based approaches over others, but treatment selection should remain diagnosis- and program-specific.
Can mindfulness replace CBT?
Sometimes a structured mindfulness-based intervention may be a reasonable alternative, but it should not be treated as a universal substitute. For GAD, CBT has stronger long-term evidence. For social anxiety, meta-analysis has found mindfulness interventions less effective than evidence-based CBT overall. For specific phobia and panic disorder, exposure-based methods address maintaining mechanisms that a generic mindfulness program may not directly target.
Can I use mindfulness while taking anxiety medication?
Mindfulness practice can be combined with medication, and some people use both. The decision to start, continue, change, or taper medication requires individualized medical guidance. Meditation should not be used as a reason to stop a prescribed medication abruptly.
Do mindfulness apps treat anxiety disorders?
Some online mindfulness programs reduce anxiety symptoms, but app evidence is heterogeneous and often involves people with elevated symptoms rather than a formally diagnosed anxiety disorder. An app is not automatically equivalent to MBSR, MBCT, CBT, or clinician-guided treatment.
Can mindfulness help even if anxiety does not disappear?
Yes. Clinically meaningful change can include less avoidance, greater ability to remain in difficult situations, less time absorbed in worry, improved functioning, and reduced reactivity even when some anxiety remains. Treatment outcomes should be tied to the person’s disorder and goals rather than to the expectation of never feeling anxious.
Can mindfulness trigger panic?
It can temporarily intensify awareness of bodily sensations or anxious thoughts for some people. That does not automatically mean the practice is harmful, but repeated severe or sustained worsening deserves attention. People with panic disorder may benefit from guidance that distinguishes mindful observation from safety behavior and integrates evidence-based panic treatment when needed.
How do I know whether anxiety is a disorder?
Diagnosis depends on the pattern, duration, severity, impairment, context, and differential diagnosis, not on whether mindfulness helps or on a single questionnaire result. A clinician may also need to consider medical conditions, medication effects, substances, sleep, and other mental-health conditions. The full framework is described in How Is Anxiety Diagnosed? Assessment, History, and Differential Diagnosis.
Related Articles
References
Farias M, Maraldi E, Wallenkampf KC, Lucchetti G. Adverse events in meditation practices and meditation-based therapies: a systematic review. Acta Psychiatrica Scandinavica. 2020;142(5):374–393. DOI: 10.1111/acps.13225. PubMed
Fortes PP, Dos Santos-Ribeiro S, de Salles-Andrade JB, et al. Mindfulness interventions and quality of life in anxiety-related disorders: a systematic review and meta-analysis. Journal of Affective Disorders. 2025;373:383–393. DOI: 10.1016/j.jad.2024.12.103. PubMed
Goldberg SB, Riordan KM, Sun S, Davidson RJ. The Empirical Status of Mindfulness-Based Interventions: A Systematic Review of 44 Meta-Analyses of Randomized Controlled Trials. Perspectives on Psychological Science. 2022;17(1):108–130. DOI: 10.1177/1745691620968771. PubMed
Goldin PR, Morrison A, Jazaieri H, Brozovich F, Heimberg R, Gross JJ. Group CBT versus MBSR for social anxiety disorder: a randomized controlled trial. Journal of Consulting and Clinical Psychology. 2016;84(5):427–437. DOI: 10.1037/ccp0000092. PubMed
Haller H, Breilmann P, Schröter M, Dobos G, Cramer H. A systematic review and meta-analysis of acceptance- and mindfulness-based interventions for DSM-5 anxiety disorders. Scientific Reports. 2021;11:20385. DOI: 10.1038/s41598-021-99882-w. PubMed
Hoge EA, Bui E, Mete M, Dutton MA, Baker AW, Simon NM. Mindfulness-Based Stress Reduction vs Escitalopram for the Treatment of Adults With Anxiety Disorders: A Randomized Clinical Trial. JAMA Psychiatry. 2023;80(1):13–21. DOI: 10.1001/jamapsychiatry.2022.3679. PubMed
Hoge EA, Mete M, Baker AW, et al. A randomized controlled trial comparing mindfulness to escitalopram for anxiety: In-person and remote, synchronous delivery pre and post COVID-19 pandemic. Journal of Affective Disorders. 2025;384:163–172. DOI: 10.1016/j.jad.2025.04.145. PubMed
Hu H, Mete M, Rustgi NK, et al. Mindfulness Meditation vs Escitalopram for Treatment of Anxiety Disorders: Secondary Analysis of a Randomized Clinical Trial. JAMA Network Open. 2024;7(10):e2438453. DOI: 10.1001/jamanetworkopen.2024.38453. PubMed
Johannsen M, Nissen ER, Lundorff M, O’Toole MS. Mediators of acceptance and mindfulness-based therapies for anxiety and depression: a systematic review and meta-analysis. Clinical Psychology Review. 2022;94:102156. DOI: 10.1016/j.cpr.2022.102156. PubMed
Liu X, Yi P, Ma L, et al. Mindfulness-based interventions for social anxiety disorder: a systematic review and meta-analysis. Psychiatry Research. 2021;300:113935. DOI: 10.1016/j.psychres.2021.113935. PubMed
National Institute for Health and Care Excellence. Generalised anxiety disorder and panic disorder in adults: management. Clinical guideline CG113. Published 2011; updated 2020. NICE recommendations
Papola D, Miguel C, Mazzaglia M, et al. Psychotherapies for Generalized Anxiety Disorder in Adults: A Systematic Review and Network Meta-Analysis of Randomized Clinical Trials. JAMA Psychiatry. 2024;81(3):250–259. DOI: 10.1001/jamapsychiatry.2023.3971. PubMed
Reangsing C, Trakooltorwong P, Maneekunwong K, Thepsaw J, Oerther S. Effects of online mindfulness-based interventions on anxiety symptoms in adults: a systematic review and meta-analysis. BMC Complementary Medicine and Therapies. 2023;23:269. DOI: 10.1186/s12906-023-04102-9. PubMed
Tong M, Qiu Y, Liu J, et al. Effectiveness of online mindfulness-based interventions based on the structured curriculum framework in improving mental health: a meta-analysis of randomized controlled trials. General Hospital Psychiatry. 2026;100:163–174. DOI: 10.1016/j.genhosppsych.2026.03.022. PubMed
Williams M, Honan C, Skromanis S, Sanderson B, Matthews AJ. Psychological Outcomes and Mechanisms of Mindfulness-Based Training for Generalised Anxiety Disorder: A Systematic Review and Meta-Analysis. Current Psychology. 2023. DOI: 10.1007/s12144-023-04695-x. PubMed
World Health Organization. Anxiety disorders. Fact sheet. 2026. WHO
World Health Organization. Stress management techniques: evidence-based recommendation for anxiety. mhGAP Evidence Centre. 2023. WHO